Who invested in ImmunoGenesis?
ImmunoGenesis's investors include Revent.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$17Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
ImmunoGenesis's investors include Revent.
ImmunoGenesis has raised $17M across 2 rounds since 2025.
ImmunoGenesis's most recent round was a Grant of $11M in Dec 2025.
Its most recent round, $11M in Dec 2025, is also its largest on record.
ImmunoGenesis's first round on record, in Jan 2025, was backed by Revent.
ImmunoGenesis's latest named round is a Grant, in Dec 2025.
ImmunoGenesis is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.